» Articles » PMID: 34276909

A Retrospective Long-Term Study on Age at Menarche and Menstrual Characteristics in 85 Young Women with Transfusion-Dependent β-Thalassemia (TDT)

Overview
Date 2021 Jul 19
PMID 34276909
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Menarche is an important milestone in a feminine reproductive life, and regular menstrual cycles reflect normal functioning of the hypothalamic-pituitary-ovarian axis, a vital sign of women's general health.

Aim Of The Study: We explored the age at menarche and the following menstrual cycles characteristics among 85 unmarried Transfusion-Dependent β-Thalassemia (TDT) women, born between 1965 and 1995, concerning iron chelation therapy (ICT) with desferrioxamine (DFO) and nutritional status, assessed by body mass index (BMI).

Results: 53 adolescents who had begun ICT before the age of 10 years experienced menarche at 13,7 ± 1,6 years (mean ± DS), whereas 32 who began treatment after ten years experienced menarche significantly later (15.5 ± 1.9 yrs; p: 0.001). At the age of menarche: BMI-Z score (n= 67, -0,09 ±1) was inversely correlated with both age at starting ICT (r = -0,39; p = 0001) and age at menarche (-0,45, p = 0,0001). Serum ferritin levels (SF) were significantly correlated with the age at starting chelation therapy (n = 79; r = 0,34; p = 0,022). In 56 TDT adolescents who developed secondary amenorrhea (SA), the SF levels were significantly higher (4,098 ± 1,907 ng/mL) compared to 23 TDT adolescents with regular menstrual cycles (2,913±782 ng/mL; p = 0,005). Nutritional status of "thinness" at menarche was associated with a lower prevalence of subsequent regular menstrual cycles and a higher prevalence of early SA.

Conclusion: An early ICT in TDT patients was associated with a normal "tempo" of pubertal onset and a higher frequency of subsequent regular menstrual cycles. In TDT patients, who developed SA, a diagnosis of acquired central hypogonadism was made, mainly due to the chronic exposure to iron overload, however other potential causes linked to nutritional status, deficient levels of circulating nutrients, and the chronic disease itself cannot be fully excluded.

Citing Articles

Beta Thalassemia in Children: Established Approaches, Old Issues, New Non-Curative Therapies, and Perspectives on Healing.

Origa R, Issa L J Clin Med. 2024; 13(22).

PMID: 39598110 PMC: 11594693. DOI: 10.3390/jcm13226966.


A Multicenter ICET-A Study on Age at Menarche and Menstrual Cycles in Patients with Transfusion-Dependent Thalassemia (TDT) who Started Early Chelation Therapy with Different Chelating Agents.

Di Maio S, Marzuillo P, Daar S, Kattamis C, Karimi M, Forough S Mediterr J Hematol Infect Dis. 2023; 15(1):e2023058.

PMID: 38028391 PMC: 10631706. DOI: 10.4084/MJHID.2023.058.


Association of GDF15 levels with body mass index and endocrine status in β-thalassaemia.

Karusheva Y, Petry C, Yasara N, Kottahachchi D, Premawardhena A, Barker P Clin Endocrinol (Oxf). 2023; 99(2):182-189.

PMID: 36806122 PMC: 10952638. DOI: 10.1111/cen.14897.


Hypomenorrhea in Adolescents and Youths: Normal Variant or Menstrual Disorder? Revision of Literature and Personal Experience.

De Sanctis V, Soliman A, Tzoulis P, Daar S, Di Maio S, Millimaggi G Acta Biomed. 2022; 93(1):e2022157.

PMID: 35315382 PMC: 8972894. DOI: 10.23750/abm.v93i1.12804.

References
1.
Wood J . Guidelines for quantifying iron overload. Hematology Am Soc Hematol Educ Program. 2015; 2014(1):210-5. DOI: 10.1182/asheducation-2014.1.210. View

2.
De Sanctis V, Bernasconi S, Bianchin L, Bona G, Bozzola M, Buzi F . Onset of menstrual cycle and menses features among secondary school girls in Italy: A questionnaire study on 3,783 students. Indian J Endocrinol Metab. 2014; 18(Suppl 1):S84-92. PMC: 4266874. DOI: 10.4103/2230-8210.140251. View

3.
Berdoukas V, Farmaki K, Carson S, Wood J, Coates T . Treating thalassemia major-related iron overload: the role of deferiprone. J Blood Med. 2012; 3:119-29. PMC: 3480237. DOI: 10.2147/JBM.S27400. View

4.
Weatherall D . Thalassemia as a global health problem: recent progress toward its control in the developing countries. Ann N Y Acad Sci. 2010; 1202:17-23. DOI: 10.1111/j.1749-6632.2010.05546.x. View

5.
Tienboon P, Sanguansermsri T, FUCHS G . Malnutrition and growth abnormalities in children with beta thalassemia major. Southeast Asian J Trop Med Public Health. 1996; 27(2):356-61. View